<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04778553</url>
  </required_header>
  <id_info>
    <org_study_id>ESX-iMOST-X1-3</org_study_id>
    <nct_id>NCT04778553</nct_id>
  </id_info>
  <brief_title>Clinical Evaluation of the iMOST-X1 Hematology Analyzer - Matrix Study</brief_title>
  <official_title>Clinical Evaluation of the iMOST Analyzer - Matrix Study Comparing Capillary and Venous Whole Blood</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Essenlix Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Essenlix Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a method comparison study for an in vitro diagnostic device. The device is a point of&#xD;
      care automated hematology analyzer which measures CBC parameters with a small drop of venous&#xD;
      or capillary, e.g., fingerstick blood. The study compared the CBC results from the test&#xD;
      device, the Essenlix iMOST X-1 to the predicate laboratory based Horiba Pentra 60C+ analyzer.&#xD;
      The CBC parameters were hemoglobin, White Blood Cells (WBC) and the WBC Differential for&#xD;
      Granulocytes, Neutrophils, Lymphocytes and Monocytes. The study subjects were patient donors&#xD;
      (age 18 and older) attending the hospital clinic from whom Informed Consent had been&#xD;
      received.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      These studies demonstrate that the iMOST X-1 system yields equivalent results to the Horiba&#xD;
      predicate system when using either capillary and venous blood specimens. Furthermore, there&#xD;
      are three alternative methods of capillary blood sampling for the iMOST and all have direct&#xD;
      applicability to the iMOST system. As has been published in the peer reviewed literature,&#xD;
      different fingerstick sample collection methods yield slightly different CBC results,&#xD;
      specifically the WBC and the WBC Differential. The iMOST employs an integrated software&#xD;
      algorithm with which the use can employ site specific calibration constants to correctly&#xD;
      match the selected capillary blood specimen to the venous specimen for the WBC test results.&#xD;
      All three methods of blood collection are thus described in the &quot;Instructions for Use&quot;.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 19, 2020</start_date>
  <completion_date type="Actual">January 21, 2021</completion_date>
  <primary_completion_date type="Actual">December 9, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Method Comparison of CBC Results</measure>
    <time_frame>October- December 2020</time_frame>
    <description>Blood Diagnostic Tests for CBC</description>
  </primary_outcome>
  <enrollment type="Actual">60</enrollment>
  <condition>Hematologic Tests</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>iMOST X-1 Hematology Analyzer</intervention_name>
    <description>The X-1 is a point of care automated hematology analyzer</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients attending the hospital outpatient clinic who had voluntarily consented to blood&#xD;
        donation for venous and capillary blood collection&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  all clinic attendees&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  unable to provide a venous and fingerstick blood specimen&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Megha Shah, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hunterdon Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hunterdon Medical Center</name>
      <address>
        <city>Flemington</city>
        <state>New Jersey</state>
        <zip>08822</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>February 26, 2021</study_first_submitted>
  <study_first_submitted_qc>February 26, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 3, 2021</study_first_posted>
  <last_update_submitted>February 26, 2021</last_update_submitted>
  <last_update_submitted_qc>February 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>CBC, WBC, Hemoglobin</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

